Clinic
Medical West Hospital Authority, An Affiliate of Uab Health System
Medical West Hospital Authority, An Affiliate of Uab Health System was paid $11.34M by Medicaid between Jan 2018 and Dec 2024, across 90 billing codes. Its largest line is 99285, emergency room visit (most serious) — 42% of everything it billed.
33Billing provider infoMEDICAL WEST HOSPITAL AUTHORITY, AN AFFILIATE OF UAB HEALTH SYSTEM
BESSEMER, AL 35022
BESSEMER, AL 35022
33aNPI1790896710assigned 08/31/2006
33bProvider typeEmergency Care Clinic/Center
28Total paid$11.34M
24GClaims359,613
24DCodes billed90
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 44,223 | $1.37M | |
| 2019 | 51,449 | $1.53M | |
| 2020 | 32,188 | $1.05M | |
| 2021 | 52,141 | $1.60M | |
| 2022 | 66,504 | $1.99M | |
| 2023 | 72,341 | $2.49M | |
| 2024incomplete | 40,767 | $1.31M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 42% | 19,463 | 17,176 | $4.81M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 16% | 46,273 | 43,371 | $1.87M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.1% | 13,524 | 12,418 | $922K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.4% | 21,483 | 19,719 | $503K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 4.2% | 12,081 | 11,270 | $471K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 4.0% | 11,864 | 11,079 | $449K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3.0% | 9,343 | 8,059 | $343K |
| 80053 | Comprehensive metabolic panel | 3.0% | 31,834 | 28,094 | $339K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.8% | 15,273 | 14,411 | $316K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.5% | 33,314 | 29,265 | $287K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.0% | 10,831 | 9,405 | $117K |
| 71045 | Radiologic examination, chest; single view | <1% | 19,329 | 17,472 | $107K |
78 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,738 | $96K |
| 81001 | <1% | 22,134 | $87K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 8,380 | $84K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 912 | $75K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 319 | $56K |
| 83690 | <1% | 7,956 | $55K | |
| 84703 | <1% | 6,143 | $40K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 10,824 | $30K |
| 84484 | <1% | 3,266 | $28K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 1,137 | $26K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 246 | $18K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 141 | $17K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 72 | $17K |
| 83880 | <1% | 558 | $16K | |
| 82553 | <1% | 1,231 | $15K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 638 | $14K |
| 81025 | <1% | 4,006 | $13K | |
| 70470 | <1% | 88 | $10K | |
| 82550 | <1% | 1,417 | $9K | |
| 80055 | <1% | 117 | $8K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 7,624 | $7K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 418 | $6K |
| 81003 | <1% | 2,091 | $6K | |
| 80306 | <1% | 502 | $6K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 507 | $5K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 46 | $5K |
| 85610 | <1% | 1,340 | $5K | |
| 87522 | Neg quan hep c or qual rna | <1% | 99 | $5K |
| 87535 | <1% | 167 | $5K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 29 | $4K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 158 | $4K |
| 86592 | <1% | 639 | $4K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 5,053 | $3K |
| 86803 | <1% | 174 | $3K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 87 | $3K |
| 90686 | <1% | 191 | $3K | |
| 82150 | <1% | 291 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 61 | $2K |
| 84439 | <1% | 231 | $2K | |
| 87807 | <1% | 125 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 233 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,231 | $1K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 12 | $1K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 434 | $1K |
| 87340 | <1% | 119 | $1K | |
| 85730 | <1% | 544 | $1K | |
| 80061 | Lipid panel | <1% | 73 | $1K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 70 | $952.26 |
| 83735 | <1% | 109 | $756.38 | |
| 87653 | <1% | 38 | $624.00 | |
| 82607 | <1% | 38 | $584.04 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 594 | $560.05 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 14 | $502.74 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 525 | $436.88 |
| 87070 | <1% | 31 | $431.73 | |
| 82677 | <1% | 13 | $391.30 | |
| 82105 | <1% | 13 | $286.13 | |
| 83021 | <1% | 14 | $184.90 | |
| 82947 | <1% | 28 | $116.25 | |
| 82330 | <1% | 15 | $100.60 | |
| 83540 | <1% | 12 | $91.80 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 14 | $46.20 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 19 | $45.76 |
| 86900 | <1% | 13 | $43.40 | |
| 86901 | <1% | 13 | $43.00 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,397 | $38.08 |
| 86140 | <1% | 16 | $32.23 | |
| 80069 | <1% | 12 | $26.67 | |
| J2704 | Injection, propofol, 10 mg | <1% | 460 | $12.63 |
| 85014 | <1% | 29 | $10.41 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 13 | $0.00 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 30 | $0.00 |
| 85041 | 0% | 14 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 263 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 200 | $0.00 |
| 82962 | 0% | 166 | $0.00 | |
| 85018 | 0% | 14 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLUTZ, MEREDITH (CQO)